InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Miller Aine. Director active across 1 company, notably Theravance Biopharma, Inc.. In total, 12 disclosures have been recorded. Activity tracked since 20 February 2024. The latest transaction was disclosed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Miller Aine is a declarant linked to Theravance Biopharma, Inc., where the listed role is SVP, DEV & HEAD OF IRE OFFICE. The declarant has 11 filings in total. In the 11 recent filings we hold, the recorded amounts are all associated with withholding tax, with dates ranging from 2024-02-22 to 2026-02-24.